Pharmacokinetics and Imaging of 212Pb-TCMC-Trastuzumab After Intraperitoneal Administration in Ovarian Cancer Patients

Predictors of Long-Term Outcome from Intraperitoneal Radioimmunotherapy for Ovarian Cancer

(2012) Ruby Meredith et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Molecular Pathways: Targeted  -Particle Radiation Therapy

(2012) K. E. Baidoo et al.   CLINICAL CANCER RESEARCH

Sensitization of Tumor to 212Pb Radioimmunotherapy by Gemcitabine Involves Initial Abrogation of G2 Arrest and Blocked DNA Damage Repair by Interference With Rad51

(2012) Kwon Joong Yong et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer model

(2011) Anna M.E. Gustafsson et al.   NUCLEAR MEDICINE AND BIOLOGY

Improved efficacy of α-particle-targeted radiation therapy

(2010) Diane E. Milenic et al.   CANCER

Bismuth-213 radioimmunotherapy with C595 anti–MUC1 monoclonal antibody in an ovarian cancer ascites model

(2010) Emma Y. Song et al.   CANCER BIOLOGY & THERAPY

MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of  -Particle Emitters for Targeted Radionuclide Therapy

(2010) G. Sgouros et al.   JOURNAL OF NUCLEAR MEDICINE

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

Intraperitoneal Alpha-Radioimmunotherapy in Mice Using Different Specific Activities

(2009) Jörgen Elgqvist et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Intraperitoneal  -Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of 211At-MX35 F(ab')2--A Phase I Study

(2009) H. Andersson et al.   JOURNAL OF NUCLEAR MEDICINE

Repeated Intraperitoneal -Radioimmunotherapy of Ovarian Cancer in Mice

(2009) Jörgen Elgqvist et al.   Journal of Oncology

Multimodality Therapy: Potentiation of High Linear Energy Transfer Radiation with Paclitaxel for the Treatment of Disseminated Peritoneal Disease

(2008) D. E. Milenic et al.   CLINICAL CANCER RESEARCH